None listed
Conditions
Interventions
Oral 40g fat(venous blood collection)
Oral 40g fat(device)
Sponsors
APO PLUS STATION CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Males and females aged 20 years or older at the time of informed consent. 2)Subjects who can make self-judgment and voluntarily gave written informed consent. 3)Subjects whose fasting neutral fat levels are 150mg/dL or more and less than 300mg/dL at a health checkup within the past year.
Exclusion criteria
Exclusion criteria: 1)Subjects who are on treatment for a serious illness. 2)Subjects who have been diagnosed with dyslipidemia, nephrotic syndrome, pancreatitis, hypothyroidism, or diabetes mellitus and who are on treatment or medication. 3)Subjects with food allergy. Subjects who are at risk of developing allergies related to the 40g high-fat meal tolerance test. 4)Subjects who regularly use licensed drugs or quasi-drugs that may affect the study. 5)Subjects who are currently on treatment at a medical institution for a disease that may affect the study. 6)Subjects who are participating in a clinical trial or have participated in another clinical trial within 1 month before the date of consent for this study. 7)Subjects who are pregnant and those who are breastfeeding. 8)Subjects who plan to participate in another clinical trial during this study period. 9)Subjects who have difficulty in wearing the prototype device. 10)Subjects who judged as unsuitable for this study by the principal investigator for any reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between the prototype device and the following neutral fat levels | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Blood glucose level by venous blood collection. 2)Blood glucose level by continuous glucose monitoring. | — |
Countries
Japan
Contacts
Public ContactMasako Mizuuchi
APO PLUS STATION CO., LTD CRO Business division
Outcome results
None listed